EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 135 filers reported holding EPIZYME INC in Q2 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,544,000 | -30.3% | 129,409 | -6.1% | 0.02% | -23.3% |
Q2 2020 | $2,214,000 | -13.8% | 137,856 | -16.7% | 0.03% | -25.0% |
Q1 2020 | $2,568,000 | -43.1% | 165,575 | -9.7% | 0.04% | +14.3% |
Q4 2019 | $4,511,000 | +140.8% | 183,384 | +1.0% | 0.04% | +133.3% |
Q3 2019 | $1,873,000 | -21.5% | 181,550 | -4.5% | 0.02% | -16.7% |
Q2 2019 | $2,386,000 | +83.0% | 190,125 | +54.6% | 0.02% | +100.0% |
Q3 2018 | $1,304,000 | -4.5% | 122,992 | +22.0% | 0.01% | 0.0% |
Q2 2018 | $1,366,000 | -17.2% | 100,842 | +8.5% | 0.01% | -30.8% |
Q1 2018 | $1,649,000 | +71.1% | 92,924 | +21.0% | 0.01% | +85.7% |
Q4 2017 | $964,000 | -12.0% | 76,773 | +33.6% | 0.01% | -12.5% |
Q3 2017 | $1,095,000 | +37.7% | 57,472 | +9.1% | 0.01% | +33.3% |
Q2 2017 | $795,000 | -7.1% | 52,675 | +5.5% | 0.01% | 0.0% |
Q1 2017 | $856,000 | +26.8% | 49,906 | -10.5% | 0.01% | +20.0% |
Q4 2016 | $675,000 | -7.2% | 55,748 | -24.5% | 0.01% | -16.7% |
Q3 2016 | $727,000 | -11.7% | 73,886 | -8.1% | 0.01% | -14.3% |
Q2 2016 | $823,000 | – | 80,387 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,488,444 | $18,680,000 | 10.50% |
Opaleye Management Inc. | 1,365,000 | $17,131,000 | 5.22% |
Palo Alto Investors LP | 6,935,074 | $87,035,000 | 4.23% |
Consonance Capital Management LP | 4,760,059 | $59,739,000 | 4.23% |
Foresite Capital Management III, LLC | 998,278 | $12,528,000 | 4.11% |
NEA Management Company, LLC | 4,377,518 | $54,938,000 | 3.85% |
Redmile Group, LLC | 8,729,142 | $109,551,000 | 3.10% |
Diametric Capital, LP | 156,575 | $1,965,000 | 1.25% |
Ghost Tree Capital, LLC | 465,000 | $5,836,000 | 1.21% |
Opus Point Partners Management, LLC | 50,378 | $632,000 | 0.94% |